Steven Cohen’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.63M Sell
117,900
-486,480
-80% -$21.9M 0.01% 1621
2026
Q2
$16.9M Buy
+604,380
New +$17M 0.02% 981
2026
Q1
– Sell
-277,924
Closed -$11M – 3771
2025
Q4
$11M Buy
+277,924
New +$10.2M 0.01% 1300
2025
Q2
– Sell
-558,348
Closed -$18M – 2169
2025
Q1
$18M Buy
+558,348
New +$20.7M 0.04% 479
2023
Q4
– Sell
-4
Closed -$175 – 2156
2023
Q3
$175 Sell
4
-183,496
-100% -$8.95M ﹤0.01% 2385
2023
Q2
$9.06M Buy
183,500
+68,281
+59% +$3.15M 0.03% 618
2023
Q1
$4.78M Buy
+115,219
New +$4.78M 0.01% 771
2022
Q3
– Sell
-24,400
Closed -$997K – 1401
2022
Q2
$997K Sell
24,400
-135,386
-85% -$6.41M ﹤0.01% 1074
2022
Q1
$10.5M Buy
159,786
+55,300
+53% +$3.58M 0.04% 491
2021
Q4
$7.26M Buy
+104,486
New +$7.59M 0.03% 593
2020
Q2
– Sell
-135,498
Closed -$4.55M – 799
2020
Q1
$4.55M Sell
135,498
-125,630
-48% -$4.52M 0.04% 395
2019
Q4
$8.49M Buy
261,128
+153,606
+143% +$4.37M 0.04% 408
2019
Q3
$2.68M Buy
+107,522
New +$3.07M 0.02% 554
2018
Q4
– Sell
-174,520
Closed -$6.11M – 959
2018
Q3
$6.11M Buy
+174,520
New +$5.53M 0.03% 549
2017
Q4
– Sell
-18,500
Closed -$414K – 905
2017
Q3
$414K Sell
18,500
-118,796
-87% -$2.69M ﹤0.01% 800
2017
Q2
$3.33M Buy
+137,296
New +$2.92M 0.02% 565
2016
Q1
– Sell
-106,700
Closed -$2.39M – 721
2015
Q4
$2.39M Buy
+106,700
New +$2.2M 0.02% 528
2014
Q3
– Sell
-300,000
Closed -$5.51M – 645
2014
Q2
$5.51M Buy
+300,000
New +$4.99M 0.04% 440

Other funds holding ATRC

Steven Cohen's ATRC Position: Q3 2026 in Review

Steven Cohen reduced its AtriCure (ATRC) stake by 80% in Q3 2026, selling an estimated $21.9M and leaving 117,900 shares worth $6.63M. The position accounts for 0.01% of the portfolio, ranked #1621.

Steven Cohen first reported a position in ATRC in Q2 2014 and has held it in 18 quarters since. The position peaked at $18M in Q1 2025. 285 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Steven Cohen held 117,900 shares of AtriCure worth $6.63M as of Q3 2026.
  • Steven Cohen sold 486,480 AtriCure shares in Q3 2026, an estimated $21.9M.
  • AtriCure made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1621 holding.
  • Steven Cohen first reported a position in AtriCure in Q2 2014 and has held it in 18 quarters since.
  • Steven Cohen's AtriCure position peaked at $18M in Q1 2025.
  • 285 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.